Replies to post #2392 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

[Semi OT] GTC holders may find this week’s SemBioSys CC on plant-derived insulin to be of interest, especially the remarks about the FDA’s attitude toward the program.

The webcast can be accessed at:
http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=1694880

[DewDiligence]

SemBioSys webcast from Needham conference:

http://www.wsw.com/webcast/needham18/sbs.to/

SemBioSys has one of the leading platforms for making drugs from transgenic plants (#msg-15925882).